Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.40
-2.05 (-5.62%)
Mar 4, 2026, 1:22 PM CST
Market Cap2.60B -27.1%
Revenue (ttm)n/a
Net Income-141.91M
EPS-1.99
Shares Out71.32M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,303
Average Volume56,440
Open36.45
Previous Close36.45
Day's Range34.40 - 36.50
52-Week Range33.30 - 56.50
Beta-0.20
RSI42.21
Earnings DateMar 6, 2026

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 48
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements